Short- and Long-Term Effects of Whole-Body Photobiomodulation in Type II Diabetes Patients: A Protocol for a Controlled Clinical Trial
NCT ID: NCT07047248
Last Updated: 2025-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
44 participants
INTERVENTIONAL
2025-08-30
2026-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Participatory Approach to Support Glucose Tolerance Tracking in Real-Life of Patients With Type 2 Diabetes
NCT06864546
Whole Body Vibration and Diabetes Type 2
NCT05968222
Telematic Program for the Treatment of Depression in Type 1 Diabetes
NCT03473704
INTEGRATED IMPACT ASSESSMENT a Telemedicine Program in the Care of Patients With Diabetes Mellitus Type 1 Intensive Treatment With Multiple Daily Injections.
NCT02784236
Using Early Time Restricted Feeding and Timed Light Therapy to Improve Glycemic Control in Adults With Type 2 Diabetes
NCT04155619
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention
A treatment with whole body red light therapy (NovoTHOR®) will be carried out
PBM
A whole body red light therapy (NovoTHOR®) will be carried out during 20 minutes
Placebo
A placebo whole body red light will be carried out
Placebo PBM
A placebo whole body red light will be carried out during 20 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PBM
A whole body red light therapy (NovoTHOR®) will be carried out during 20 minutes
Placebo PBM
A placebo whole body red light will be carried out during 20 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with Type 2 Diabetes Mellitus (T2DM) according to the American Diabetes Association (ADA) criteria.
* HbA1c levels between 6.5% and 10% at screening.
* Stable diabetes management regimen (medications and lifestyle) for at least three months prior to enrollment
Exclusion Criteria
* History of photosensitivity or medical conditions exacerbated by light exposure.
* Use of medications or supplements known to significantly alter glucose metabolism, other than current stable diabetes management.
* Pregnant or lactating women.
30 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
clinical professor
UNKNOWN
University of Malaga
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel Aguilar Nunez
danunez
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr
Granada, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PBM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.